Oxybutynin Chloride
NDC 72888-030, Oxybutynin Chloride, tablet, extended release, from Advagen Pharma Limited.
- Product NDC
- 72888-030
- Status
- Listed
- Labeler
- Advagen Pharma Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214415
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72888-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72888-030-01 | 72888003001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-01) |
| 72888-030-05 | 72888003005 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-05) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7bd31561-4c76-4c6b-819b-492549886673NADAC price for package 72888003001
GET /v1/drugs/nadac/72888003001NADAC price for package 72888003005
GET /v1/drugs/nadac/72888003005
Use it
Look up 72888-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72888-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72888-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.